DYNAVAX TECHNOLOGIES CORP Logo

DYNAVAX TECHNOLOGIES CORP

Biopharmaceutical company developing and commercializing vaccines and adjuvant technology.

DVAX | US

Overview

Corporate Details

ISIN(s):
US2681582019
LEI:
Country:
United States of America
Address:
2100 POWELL STREET, 94608 EMERYVILLE

Description

Dynavax Technologies Corp. is a commercial-stage biopharmaceutical company focused on developing and commercializing vaccines to prevent infectious diseases. The company's core strength lies in its proprietary Toll-like Receptor (TLR) immune-modulating technology. Its lead commercial product is HEPLISAV-B, an adult hepatitis B vaccine that utilizes the company's CpG 1018 adjuvant to enhance the immune response. In addition to marketing its own vaccines, Dynavax supplies its CpG 1018 adjuvant to other companies for use in their vaccine development programs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-13 19:47
FORM 4
English 7.4 KB
2025-06-13 19:44
FORM 4
English 7.5 KB
2025-06-13 19:42
FORM 4
English 7.4 KB
2025-06-13 19:39
FORM 4
English 7.5 KB
2025-06-09 14:00
DFAN14A
English 22.5 KB
2025-06-09 09:44
DEFA14A
English 18.2 KB
2025-06-06 08:04
DEFA14A
English 21.3 KB
2025-06-05 19:21
DEFA14A
English 38.2 KB
2025-06-04 19:09
DEFA14A
English 20.0 KB
2025-06-04 15:40
DFAN14A
English 20.5 KB
2025-05-23 22:54
DFAN14A
English 20.0 KB
2025-05-23 18:01
DEFA14A
English 17.8 KB
2025-05-19 18:30
DEFA14A
English 39.2 KB
2025-05-19 18:04
DFAN14A
English 8.6 MB
2025-05-15 21:11
DFAN14A
English 23.4 KB

Automate Your Workflow. Get a real-time feed of all DYNAVAX TECHNOLOGIES CORP filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DYNAVAX TECHNOLOGIES CORP

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DYNAVAX TECHNOLOGIES CORP via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.